Definition:Preauthorization
🏥 Preauthorization — also called prior authorization or pre-certification — is a cost-control mechanism used primarily in health insurance whereby a policyholder or healthcare provider must obtain the insurer's approval before a proposed medical service, procedure, or prescription drug will be covered under the policy. The requirement ensures that the treatment meets the plan's criteria for medical necessity, clinical appropriateness, and cost-effectiveness before the insurer commits to payment. While most closely associated with the US managed-care system, preauthorization practices appear in various forms across private health insurance markets in the Middle East, parts of Asia, and increasingly in supplemental health products offered in Europe.
⚙️ The process typically begins when a treating physician submits a preauthorization request to the insurer or its third-party administrator, including clinical documentation that justifies the proposed course of care. The insurer's medical review team — often supported by clinical guidelines, AI-driven decision tools, and utilization management protocols — evaluates the request against coverage criteria and either approves, denies, or requests additional information. Turnaround times vary: routine requests may be processed within hours, while complex cases involving expensive therapies or experimental treatments can take days. Dissatisfied policyholders or providers can typically invoke an appeals process, and regulators in several US states have enacted prompt-decision laws that cap the time an insurer can take to respond. Digital transformation is reshaping this workflow: electronic prior authorization platforms and API-based integrations between provider and payer systems aim to reduce the administrative burden that has made preauthorization one of the most criticized aspects of the health insurance experience.
💰 Preauthorization occupies a contentious space between cost containment and care access. For insurers, it is one of the most effective tools for managing medical loss ratios, preventing unnecessary procedures, steering patients toward evidence-based treatments, and controlling exposure to high-cost specialty drugs and services. For providers and patients, however, it can introduce delays that affect clinical outcomes, generate significant administrative expense, and create friction in the care delivery process. Regulatory scrutiny has intensified: US federal rules under the CMS interoperability framework are pushing health plans toward faster electronic authorization, and several markets in the Gulf Cooperation Council require real-time digital preauthorization for hospital admissions. The ongoing challenge for health insurers worldwide is calibrating preauthorization programs to capture genuine savings without undermining the policyholder experience or provoking regulatory backlash.
Related concepts: